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Abstract: The main aim of this study was to isolate and characterize the active compounds 
from the hexane extract of the fruit peels of Citrus aurantiifolia, which showed activity 
against one sensitive and three monoresistant (isoniazid, streptomycin or ethambutol) strains 
of Mycobacterium tuberculosis H37Rv. The active extract was fractionated by column 
chromatography, yielding the following major compounds: 5-geranyloxypsoralen (1);  
5-geranyloxy-7-methoxycoumarin (2); 5,7-dimethoxycoumarin (3); 5-methoxypsoralen (4); 
and 5,8-dimethoxypsoralen (5). The structures of these compounds were elucidated by 1D 
and 2D NMR spectroscopy. In addition, GC-MS analysis of the hexane extract allowed  
the identification of 44 volatile compounds, being 5,7-dimethoxycoumarin (15.79%),  
3-methyl-1,2-cyclopentanedione (8.27%), 1-methoxy-ciclohexene (8.0%), corylone 
(6.93%), palmitic acid (6.89%), 5,8-dimethoxypsoralen (6.08%), -terpineol (5.97%), and 
umbelliferone (4.36%), the major constituents. Four isolated coumarins and 16 commercial 
compounds identified by GC-MS were tested against M. tuberculosis H37Rv and three 
multidrug-resistant M. tuberculosis strains using the Microplate Alamar Blue Assay. The 
constituents that showed activity against all strains were 5 (MICs = 25–50 g/mL),  
1 (MICs = 50–100 g/mL), palmitic acid (MICs = 25–50 g/mL), linoleic acid  
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(MICs = 50–100 g/mL), oleic acid (MICs = 100 g/mL), 4-hexen-3-one  
(MICs = 50–100 g/mL), and citral (MICs = 50–100 g/mL). Compound 5 and palmitic 
acid were the most active ones. The antimycobacterial activity of the hexane extract of  
C. aurantifolia could be attributed to these compounds.  
Keywords: Citrus aurantifolia; Mycobacterium tuberculosis; multidrug resistant; 
coumarins; fatty acids; GC-MS analysis 
 
1. Introduction 
With 8.9–9.9 million new and relapse cases reported every year, tuberculosis is still a matter of 
concern for many scientists around the World [1]. Tuberculosis is an infectious disease caused mainly 
by Mycobacterium tuberculosis, a bacterium that has developed resistance to first and second line 
antitubercular drugs. Efforts to treat and cure tuberculosis have been relatively unsuccessful due to the 
emergence of multi-drug resistant strains of M. tuberculosis, together with an increased incidence of 
new tuberculosis cases, including those associated to the Human Immunodeficiency Virus (HIV) [2]. 
Therefore, ongoing research is focused on the discovery of new antitubercular compounds with 
improved efficacy, safety, and potency. In some recent reviews, plants, marine organisms, fungi, and 
bacteria have all been reported as promising sources of antimycobacterial natural products, which 
could be considered for further drug research and development [3–7]. In the meantime, our research 
group has directed efforts to the discovery of new antimycobacterial compounds from some Mexican 
medicinal plants [8–11]. 
Mexican lime, Citrus aurantifolia (Christim) Swingle (Rutaceae) was recently postulated to be a 
hybrid between citron (a cluster of C. medica and C. indica) and C. micrantha by phylogenetic  
studies and is considered as a native species from Southeast Asia (Indo-Malayan region) [12].  
C. aurantifolia is widespread in tropical and subtropical regions around the World such as  
North America (Florida, Texas, California, Mexico, etc.), India, Egypt, and Central America [13]. 
Lime essential oils are not only used as flavoring agents in beverages, manufactured foods, and 
pharmaceutical forms, but also as ingredients in perfumes [13]. Additionally, C. aurantifolia is used in 
traditional medicine as an antiseptic, anthelmintic, mosquito bite repellent, for stomach ailments, tonic, 
antiscorbutic, astringent, diuretic, headache, arthritis, digestive and appetite stimulant, and for colds, 
coughs and sore throats [13,14]. Previous investigations of C. aurantifolia have reported flavonoids, 
coumarins, and terpenoids [15–18]. Peel oil of C. auranifolia has been analyzed by GC-MS  
analysis several times [19,20]. Lime peel oil has shown antimicrobial [21], radical scavenging,  
anti-cholinesterase [22], anthelmintic [23], and anticancer activities [24]. Furthermore, leaves of lime 
showed protective effect against osteoporosis [25] and induced platelet aggregation [17]. 
Recently, our research group reported that the hexane extract of fruit peels of C. aurantifolia 
exhibited important activity against isoniazid, streptomycin or ethambutol monoresistant  
M. tuberculosis strains with minimum inhibitory concentrations (MIC) in the 25 to 50 g/mL range [8]. 
Therefore, the oily extract was subjected to further chemical and antimycobacterial studies in order to 
identify the active compounds.  
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2. Results and Discussion 
2.1. Isolation and Structure Characterization of C. aurantifolia Constituents 
The active hexane extract was fractionated by column chromatography (CC). The fractions were 
subjected to several chromatographic procedures to yield compounds 1–5. The structure of these 
compounds were established by 1D and 2D NMR spectra as 5-geranyloxypsoralen (bergamottin, 1) [26], 
5-geranyloxy-7-methoxycoumarin (2) [27], 5,7-dimethoxycoumarin (limettin, 3) [28], 5-methoxy-
psoralen (bergapten, 4) [29], and 5,8-dimethoxypsoralen (isopimpinellin, 5) [30] (Figure 1). It is worth 
mentioning that the 1H-NMR spectra for compounds 1 and 4 at 700 MHz exhibited long-range 
coupling constant values for the H4, H8, H3' protons (see Experimental section), which is a condition 
previously reported for polycyclic aromatics [31]. Five-bond coupling constants (5J) were observed for 
protons H8 (t, 5JH4,H8, 5JH3',H8 = 0.7 Hz), H4 (dd, 5JH4,H8 = 0.7 and 3JH3,H4 = 9.8 Hz), and H3' (dd,  
5JH3',H8 = 0.7 and 3JH3',H2' = 2.8 Hz) in furanocoumarin 1. Similar long-range coupling constant patterns 
were observed for protons H8 (dd, 5JH4,H8 = 0.7 and 5JH3',H8 = 1.4 Hz), H4 (dd, 5JH4,H8 = 0.7 and  
3JH3,H4 = 9.8 Hz), and H3' (dd, 5JH3',H8 = 1.4 and 3JH3',H2' = 2.1 Hz) in compound 4. 
Figure 1. Chemical structures of isolated coumarins. 
 
2.2. GC-MS Analysis 
The GC-MS analysis of the hexane extract of C. aurantifolia fruit peel led to the identification of 44 
volatile components, including monoterpenes (16.00%), sesquiterpenes (6.55%), coumarins (27.37%), 
fatty acids (9.78%), and some other oxygenated aromatic and non-aromatic compounds (40.30%) 
(Table 1). The main components were identified as 5,7-dimethoxycoumarin (3, 15.79%), 3-methyl-1,2-
cyclopentanedione (8.27%), 1-methoxy-cyclohexene (8.0%), corylone (6.93%), palmitic acid (6.89%), 
5,8-dimethoxypsoralen (5, 6.08%), -terpineol (5.97%), and umbelliferone (4.36%).  
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Table 1. Volatile constituents from the hexane extract of C. aurantifolia. 
Peak Compound RT a RI b %c 
1 Tetrahydro-2-methyl-2H-pyran  5.25 838 0.72 
2 4-Hexen-3-one  5.54 855 0.51 
3 3-Methyl-3-penten-2-one  5.61 859 0.33 
4 3-Hexen-2-one  5.67 862 0.48 
5 2,3-Dimethyl-2,3-butanediol  6.30 898 1.67 
6 Resorcinol  8.35 1016 3.65 
7 p-Cymene 8.85 1046 0.36 
8 1-Methoxycyclohexene  9.56 1089 8.00 
9 Linalool oxide 9.97 1115 1.18 
10 Crysantenile acetate  10.60 1156 0.40 
11 Corylone  10.92 1177 6.93 
12 Terpinen-4-ol  11.47 1213 1.66 
13 -Terpineol  11.74 1232 5.97 
14 3-Methyl-1,2-cyclopentanedione  12.10 1257 8.27 
15 3,7-Dimethyl-(Z)-2,6-octadienal  12.36 1276 1.09 
16 Carvone 12.49 1284 0.88 
17 Geraniol  12.60 1292 1.15 
18 Citral  12.77 1305 2.21 
19 1,8-Dimethyl-4-(1-methylethyl)-spiro[4.5]dec-8-en-7-one  12.96 1318 0.56 
20 Geranyl formate  13.11 1329 0.70 
21 Oleic acid  13.93 1390 0.69 
22 7-Methyl-(Z)-8-tetradecen-1-ol acetate  14.20 1410 2.83 
23 Geranyl acetone  14.78 1455 1.84 
24 Bergamotene  14.96 1470 1.00 
25 (Z)-8-Methyl-9-tetradecenoic acid  15.28 1494 1.24 
26 trans--Bisabolene  15.89 1545 1.02 
27 Caryophyllene oxide  17.05 1643 3.02 
28 Spathulenol  17.60 1691 1.95 
29 Umbelliferone  19.06 1828 4.36 
30 (Z)-11(13,14-Epoxy)tetradecen-1-ol acetate  19.29 1849 0.59 
31 trans-Phytol  19.52 1872 0.22 
32 1-Heptatriacontanol  19.65 1884 0.42 
33 Versalide  20.08 1926 0.51 
34 Methyl palmitate  20.45 1964 0.29 
35 Palmitic acid  21.19 2031 6.89 
36 5,7-Dimethoxycoumarin  21.83 2083 15.80
37 5-Methoxypsoralen 22.55 2154 1.14 
38 Linoleic acid  22.77 2179 0.96 
39 Tricosane  23.88 2305 0.31 
40 5,8-Dimethoxypsoralen  24.12 2332 6.08 
41 Pentacosane  25.86 2506 0.46 
42 Tetracosanal  27.80 2650 0.70 
43 Octacosane  28.78 2711 0.39 
44 Nonacosane  33.40 2915 0.50 
a RT Retention time (min); b RI Retention index calculated for each compound; c % Relative 
abundances from the peak area integration. 
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Chemical differences in the composition of essential lime oils should be considered when an 
extraction process is proposed, which could account for the presence or absence of active compounds 
against specific diseases. Previous GC-MS chemical studies of essential oils obtained from fruit  
or leaves of C. aurantifolia have been reported to account for slight chemo-qualitative and  
chemo-quantitative differences, depending on which country the limes came from. The fruit peel 
essential oil of Iranian C. aurantifolia was reported to contain 50 compounds, having limonene 
(53.53%), -terpineol (9.41%), and -terpinene (6.26%) as the most abundant [21]. Distilled oil of fruit 
peels of C. aurantifolia from southern Florida was studied by GC-MS detecting between 50 to  
60 volatiles with limonene (32.6%), -terpineol (12.5%), and -pinene (6.3%) as the main  
compounds [20]. On the other hand, an Australian research group reported the analysis of the  
essential oil of Mexican peel lime with limonene (30.5%) and -terpinene (19.2%) as the main 
components, together with some minor constituents as geranial (5.9%), 7-methoxycoumarin (3.3%),  
5,7-dimethoxycoumarin (6.6%), and bergapten (2.9%) [32]. These reports showed that limonene and 
-terpineol are the most common and abundant components of the essential oil of C. aurantifolia.  
A chemical reinvestigation of Mexican lime oil of C. aurantifolia led to the identification of 98 
compounds, suggesting that during distillation, lime oil undergoes modifications in its chemical 
composition because heating of the juice-oil emulsion and an acidic environment provoke transformations 
that generate more stable compounds. Authors provided insights into the acid catalyzed hydrolysis and 
rearrangement reactions of the bicyclic hydrocarbons named - and -terpinene, sabinene, and -thujene, 
which generate alcohols (-terpineol, terpinen-4-ol, endo-fenchol, borneol, isoborneol) and hydrocarbons 
(terpinolene, limonene, fenchene, camphene, -terpinene, -terpinene) [33]. These insights could explain 
at some point the chemo-qualitative and chemo-quantitative differences from one sample to another. It 
is worth mention that the extraction processes of oils accounted for those chemical differences. 
Chemo-qualitative analysis of the volatile components exhibited substantial differences between the 
hexane extract of this research and the distilled oil of C. aurantifolia of previous reports, detecting  
5,7-dimethoxycoumarin, 5,8-dimethoxypsoralen, and -terpineol as the most abundant constituents, in 
contrast to limonene and -terpineol of the distilled oil. Previous studies of essential lime oils reported 
limonene as the most abundant component, but in this work limonene is found in trace amounts in the 
hexane extract.  
2.3. Antimycobacterial Activity of Constituents from C. aurantifolia 
Four isolated compounds and sixteen commercial substances identified by GC-MS were evaluated 
against sensitive and multidrug-resistant M. tuberculosis strains. The molecules that showed activity 
against all strains were 5,8-dimethoxypsoralen (5, MICs = 25–50 g/mL), 5-geranyloxypsoralen  
(1, MICs = 50−100 g/mL), palmitic acid (MICs = 25−50 g/mL), linoleic acid (MICs = 50−100 g/mL), 
oleic acid (MICs = 100 g/mL), 4-hexen-3-one (MICs = 50−100 g/mL), and citral (MICs = 50 g/mL). 
All tested compounds exhibited less antimycobacterial activity than the positive controls used, 
ethambutol, isoniazid and rifampicin (Table 2).  
Biological results showed that 5,8-dimethoxypsoralen (5) inhibited cellular growth of  
multidrug-resistant M. tuberculosis strains with MIC values in the range of 25–50 g/mL. Analysis of 
the structure-activity relationship between coumarins and furanocoumarins indicates that furan moiety 
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contributes to potency, as can be observed for furanocoumarins 5 (MICs = 25 and 50 g/mL) and 1 
(MICs = 50 and 100 g/mL) in comparison to coumarins 2 and 3 (MICs > 200 g/mL) (Table 2). The 
possible mechanism of action could be related to previous reports in which certain furanocoumarins 
can not only intercalate into deoxyribonucleic acid (DNA) and create cross-links with thymidine 
residues, but also can form covalent links to apoproteins and permanently inactivate cytochrome P450 
enzymes [34]. It has been reported in the literature that compound 5 possesses antimicrobial [35], 
spasmogenic [36], cardiovascular [37], cancer chemopreventive [38], vasorelaxing [39], and  
non-phototoxic effects [40,41]. Additionally, compound 1 possesses antimutagenic effects [42] and it 
is a cancer chemopreventive agent [43].  
Table 2. MIC values (g/mL) of constituents from C. aurantifolia against M. tuberculosis. 
Compound H37Rv a H10 b M15 c M26 d 
5-Geranyloxypsoralen (1) 50 200 100 100 
5-Geranyloxy-7-methoxycoumarin (2)  200 200 100 100 
5,7-Dimethoxycoumarin (3)  >200 NT NT NT 
5,8-Dimethoxypsoralen (5) 25 25 >50 50 
4-Hexen-3-one  50 >200 >200 >200 
3-Methyl-3-penten-2-one  >200 NT NT NT 
Resorcinol >200 NT NT NT 
p-Cymene >200 NT NT NT 
Linalool oxide >200 NT NT NT 
Terpinen-4-ol  200 >200 >200 >200 
3-Methyl-1,2-cyclopentanedione  >200 NT NT NT 
Carvone 200 >200 >200 >200 
Geraniol  200 >200 >200 >200 
Citral  50 >200 >200 200 
Geranyl formate  >200 NT NT NT 
Oleic acid  100 100 100 100 
Methyl palmitate  >200 NT NT NT 
Palmitic acid  25 50 50 50 
Linoleic acid  50 100 100 100 
Pinacol  >200 NT NT NT 
Ethambutol 2.0 15 15 15 
Isoniazid 0.02 5 7 6 
Rifampicin 0.08 9 10 12 
a M. tuberculosis H37Rv strain is sensitive to isoniazid, rifampicin, streptomycin and ethambutol; 
b,c,d M. tuberculosis H10, M15 and M26 are clinical strains resistant to isoniazid and rifampicin; 
NT: Not tested. 
The saturated fatty acid palmitic acid exhibited higher activity against multidrug-resistant  
M. tuberculosis strains (MICs = 50 g/mL) than the unsaturated fatty acids oleic acid and linoleic acid, 
which showed less activity (MICs = 100 g/mL). Saravanakumar’s research group reported the 
activity of oleic acid (MIC 25 µg/mL), linoleic acid (MIC 50 µg/mL), and palmitic acid (no 
significant) against M. tuberculosis H37Rv using the Bactec-460 method [44]. For both studies, there 
was agreement for linoleic acid (MIC 50 µg/mL). However, in this study, the results for oleic acid 
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(MIC 100 µg/mL) and palmitic acid (MIC 25 µg/mL) against H37Rv using the Microplate Alamar 
Blue Assay were the opposite of those reported by Saravanakumar. On the other hand, Hirsch and 
Barchet published the bacteriostatic activity of saturated fatty acids C10–C16 against M. tuberculosis 
and those results are in agreement with the antimycobacterial activity of palmitic acid (C16:0) found in 
our study [45]. Reports in the literature have shown that long-chain unsaturated fatty acids such as 
oleic and linoleic acid are selective inhibitors of the enoyl-acyl carrier protein reductase (FabI), which 
account for their antibacterial activities through the inhibition of fatty acid synthesis [46]. Therefore, 
these experimental findings could be considered to explain the antimycobacterial activities of oleic and 
linoleic acids.  
3. Experimental  
3.1. General Experimental Procedures 
1D and 2D NMR spectra were recorded on Varian spectrometers at 400 and 700 MHz using CDCl3 
as solvent and TMS as the internal standard. CC was carried out to fractionate the active extract. 
Fractions were monitored by Si gel thin layer chromatography and observed under UV light at 254 and 
364 nm. The analysis of volatile constituents of hexane extract was performed on a HP Agilent 
Technologies 6890 gas chromatograph equipped with a MSD 5973 quadrupole mass detector  
(HP Agilent, CA, USA) in electron impact mode at 70 eV. On the other hand, in vitro anti-tuberculosis 
test was performed using the Alamar Blue microassay. 
3.2. Chemicals 
Silica gel (70–230 mesh, Merck). Precoated silica gel Al foils (Fluka). All solvents used were 
analytical grade (CTR México). C7-C40 n-alkanes, dimethyl sulphoxide (DMSO), glycerol, Tween 80, 
4-hexen-3-one, 3-methyl-3-penten-2-one, resorcinol, p-cymene, linalool oxide, terpinen-4-ol,  
3-methyl-1,2-cyclopentanedione, carvone, geraniol, citral, geranyl formate, oleic acid, methyl 
palmitate, palmitic acid, linoleic acid, pinacol, ethambutol, isoniazid, rifampicin were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Middlebrook 7H9 broth and OADC (oleic acid-album-dextrosa-
catalasa) from Becton Dickinson Co. (Franklin Lakes, NJ, USA), and Alamar blue solution from Trek 
Diagnostic (Westlake, OH, USA). 
3.3. Mycobacterium Tuberculosis Strains 
M. tuberculosis H37Rv (27294) sensitive to all five first-line antituberculosis drugs (streptomycin, 
isoniazid, rifampicin, ethambutol and pirazinamide) was obtained from the American Type Culture 
Collection (ATCC). Multidrug resistant M. tuberculosis H10, M15, and M26 strains were obtained 
from sputum of tuberculosis patients. These specimens were kindly provided by Dr. Virgilio 
Bocanegra-García from the Centro de Biotecnología Genomica del Instituto Politécnico Nacional. The 
local ethics committee approved all protocols used in this study. 
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3.4. Plant Material 
Fruits and flowering branches of Citrus aurantifolia were collected in Montemorelos, Nuevo León, 
México in May 2009. A voucher specimen (Number: 024769) was deposited at the Herbarium of the 
Faculty of Biological Sciences of the Autonomous University of Nuevo León.  
3.5. Extraction and Isolation of Constituents from C. aurantifolia 
Peels (1.4 kg) were removed from fresh fruits (7.8 kg) and macerated twice with n-hexane (6 L) for 
72 h at room temperature. Solvent was removed under reduced pressure to give a yellowish oily 
residue (16.05 g). The n-hexane extract (16.00 g) was subjected to silica gel CC with gradient elution 
of hexane–EtOAc affording 24 fractions (F1 100:0; F2 95:5; F3-7 90:10; F8-13 85:15; F14-16 80:20; 
F17-18 75:25; F19 70:30; F20 60:40; F21 50:50; F22 40:60; F23 30:70-10:90; F24 0:100 hex/EtOAc). 
Fraction 3 (640 mg) eluted with hexane–EtOAc (90:10) was subjected to silica gel CC with gradient 
elution as above. Sub-fractions eluted with 98:2 hexane–EtOAc led to the purification of 24.8 mg of 1 
as a yellowish oily compound. Fraction 5 (1.16 g) eluted with hexane–EtOAc (90:10) afforded a white 
solid, which was recrystallized from hexane–EtOAc (97:3) to give 17.6 mg of 2. Fractions 9–10  
(150 mg) obtained from hexane–EtOAc (85:15) gave a white precipitate which was recrystallized in 
chloroform to give 10.7 mg of 3 as colorless needles. Fractions 11–12 (440 mg) obtained from  
hexane–EtOAc (85:15) were similarly subjected to silica gel CC with gradient elution using  
hexane–EtOAc. Sub-fractions 61–120 (hexane–EtOAc, 96:4) afforded 56.2 mg of 4 as a yellow solid. 
Fractions 13–15 (560 mg) eluted with hexane–EtOAc (80:20) were chromatographed as above.  
Sub-fractions eluted with 95:5 hexane–EtOAc gave 4 mg of 5 as a yellow solid. 
3.6. Spectroscopical Data 
5-Geranyloxypsoralen (1). 1H-NMR (700 MHz, CDCl3) : 8.17 (1H, dd, J = 9.8, 0.7 Hz, H-4), 7.59 
(1H, d, J = 2.8 Hz, H-2'), 7.16 (1H, t, J = 0.7 Hz, H-8), 6.96 (1H, dd, J = 2.8, 0.7 Hz, H-3'), 6.27 (1H, 
d, J = 9.8  Hz, H-3), 5.53 (1H, tq, J = 6.3, 1.4 Hz, H-2"), 5.06 (1H, m, H-6"), 4.95 (2H, d, J = 6.3 Hz, 
H-1"), 2.09 (4H, m, H-5" y H-4"), 1.69 (3H, d, J = 0.7 Hz, H-9"), 1.68 (3H, d, J = 0.7 Hz, H-8"), 1.60 
(3H, d, J = 0.7 Hz, H-10"). 13C-NMR (176 MHz, CDCl3) : 161.57 (C-2), 158.34 (C-7), 152.86 (C-8a), 
149.5 (C-5), 145.18 (C-2'), 143.27 (C-3"), 139.86 (C-4), 132.27 (C-7"), 123.69 (C-6"), 119.05 (C-2"), 
114.27 (C-6), 112.77 (C-3), 107.73 (C-4a), 105.28 (C-3'), 94.45 (C-8), 69.95 (C-1"), 39.71 (C-4"), 
26.40 (C-5"), 25.90 (C-8"), 17.94 (C-9"), 16.90 (C-10").  
5,7-Dimethoxycoumarin (3). 1H-NMR (400 MHz, CDCl3) : 7.97 (1H, d, J = 9.6 Hz, H-4), 6.42 (1H, 
d, J = 2 Hz, H-8), 6.28 (1H, d, J = 2.4 Hz, H-6), 6.16 (1H, d, J = 9.6 Hz, H-3), 3.89 (3H, s, 7-OCH3), 
3.85 (3H, s, 5-OCH3). 13C-NMR (100 MHz, CDCl3) : 163.65 (C-2), 161.57 (C-7), 156.92 (C-5), 
156.76 (C-10), 138.77 (C-4), 110.89 (C-3), 103.96 (C-9), 94.80 (C-6), 92.72 (C-8), 55.91 (CH3O-7), 
55.78 (CH3O-5). 
5-Methoxypsoralen (4). 1H-NMR (700 MHz, CDCl3) : 8.16 (1H, dd, J = 9.8, 0.7 Hz, H-4), 7.6 (1H, d, 
J = 2.8 Hz, H-2'), 7.14 (1H, dd, J = 1.4, 0.7 Hz, H-8), 7.02 (1H, dd, J = 2.1, 1.4 Hz, H-3'), 6.28 (1H, d, 
J = 9.8 Hz, H-3), 4.27 (3H, s, 5-OCH3). 13C-NMR (176 MHz, CDCl3) : 161.53 (C-2), 158.59 (C-7), 
Molecules 2012, 17 11181 
 
 
152.90 (C-4a), 149.78 (C-5), 145.01 (C-2'), 139.53 (C-4), 112.87 (C-6), 112.76 (C-3), 106.61 (C-8a), 
105.26 (C-3'), 94.07 (C-8), 60.30 (5-OCH3).  
3.7. GC-MS Analysis 
Chemical composition of volatile compounds from the active hexane extract was analysed on a gas 
chromatograph equipped with a quadrupole mass detector in electron impact mode at 70 eV. Volatile 
compounds were separated on a HP 5MS capillary column (25 m long, 0.2 mm i.d., 0.3 m film 
thickness). The oven temperature was set at 40 °C for 2 min and then programmed from 40 to 260 °C 
at 10 °C/min, and keep it 20 min at 260 °C. Mass detector conditions were as follows: interphase 
temperature 200 °C and mass acquisition range 20–550. Temperature of injector and detector were set 
to 250 °C and 280 °C, respectively. The splitless injection mode was carried out with 1 L of  
oily extract. The carrier gas was helium at a flow rate of 1 mL/min. Identification of volatiles was 
performed comparing their mass spectra with those of the National Institute of Standards and 
Technology NIST 1.7 library. In addition, a standard solution of C7-C40-alkanes was used to obtain 
the retention index of compounds and comparing them with literature data [47]. Semi-quantitative data 
were calculated from the GC peak areas without using correction factors and were expressed as 
relative percentage (peak area %) of the total volatile constituents identified. 
3.8. Antimycobacterial Activity 
The activity of all compounds against the M. tuberculosis strains was determined using the 
Microplate Alamar Blue Assay (MABA) as previously described in the literature [8,9]. 
4. Conclusions  
5,8-Dimethoxypsoralen (5, MICs = 25−50 g/mL), 5-geranyloxypsoralen (1, MICs = 50−100 g/mL), 
palmitic acid (MICs = 25−50 g/mL), linoleic acid (MICs = 50−100 g/mL), oleic acid  
(MICs = 100 g/mL), 4-hexen-3-one (MICs = 50−100 g/mL), and citral (MICs = 50 g/mL) are 
responsible for the antimycobacterial activity observed in C. aurantifolia. Compound 5 and palmitic 
acid were the most active constituents. Utilization of these compounds for therapeutic purposes will 
require the evaluation of their cytotoxic activities and determination of their index values.  
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